234 related articles for article (PubMed ID: 15610846)
21. Insights into the biosynthesis of the benzoquinone ansamycins geldanamycin and herbimycin, obtained by gene sequencing and disruption.
Rascher A; Hu Z; Buchanan GO; Reid R; Hutchinson CR
Appl Environ Microbiol; 2005 Aug; 71(8):4862-71. PubMed ID: 16085885
[TBL] [Abstract][Full Text] [Related]
22. A new post-PKS modification process in the carbamoyltransferase gene inactivation strain of Streptomyces hygroscopicus 17997.
Li Y; He W; Wang Y; Wang Y; Shao R
J Antibiot (Tokyo); 2008 Jun; 61(6):347-55. PubMed ID: 18667782
[TBL] [Abstract][Full Text] [Related]
23. The LuxR family members GdmRI and GdmRII are positive regulators of geldanamycin biosynthesis in Streptomyces hygroscopicus 17997.
He W; Lei J; Liu Y; Wang Y
Arch Microbiol; 2008 May; 189(5):501-10. PubMed ID: 18214443
[TBL] [Abstract][Full Text] [Related]
24. New, highly active nonbenzoquinone geldanamycin derivatives by using mutasynthesis.
Eichner S; Floss HG; Sasse F; Kirschning A
Chembiochem; 2009 Jul; 10(11):1801-5. PubMed ID: 19554593
[No Abstract] [Full Text] [Related]
25. Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.
Chiosis G; Caldas Lopes E; Solit D
Curr Opin Investig Drugs; 2006 Jun; 7(6):534-41. PubMed ID: 16784024
[TBL] [Abstract][Full Text] [Related]
26. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
Kim T; Keum G; Pae AN
Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970
[TBL] [Abstract][Full Text] [Related]
27. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
[TBL] [Abstract][Full Text] [Related]
28. The missing C-17 O-methyltransferase in geldanamycin biosynthesis.
Yin M; Lu T; Zhao LX; Chen Y; Huang SX; Lohman JR; Xu LH; Jiang CL; Shen B
Org Lett; 2011 Jul; 13(14):3726-9. PubMed ID: 21682254
[TBL] [Abstract][Full Text] [Related]
29. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.
Moser C; Lang SA; Stoeltzing O
Anticancer Res; 2009 Jun; 29(6):2031-42. PubMed ID: 19528462
[TBL] [Abstract][Full Text] [Related]
30. Cloning and characterization of a gene cluster for geldanamycin production in Streptomyces hygroscopicus NRRL 3602.
Rascher A; Hu Z; Viswanathan N; Schirmer A; Reid R; Nierman WC; Lewis M; Hutchinson CR
FEMS Microbiol Lett; 2003 Jan; 218(2):223-30. PubMed ID: 12586396
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models.
Banerji U; Walton M; Raynaud F; Grimshaw R; Kelland L; Valenti M; Judson I; Workman P
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7023-32. PubMed ID: 16203796
[TBL] [Abstract][Full Text] [Related]
32. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM
Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259
[TBL] [Abstract][Full Text] [Related]
33. Biosynthesis of the heat-shock protein 90 inhibitor geldanamycin: new insight into the formation of the benzoquinone moiety.
Lee D; Lee K; Cai XF; Dat NT; Boovanahalli SK; Lee M; Shin JC; Kim W; Jeong JK; Lee JS; Lee CH; Lee JH; Hong YS; Lee JJ
Chembiochem; 2006 Feb; 7(2):246-8. PubMed ID: 16381049
[No Abstract] [Full Text] [Related]
34. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
[TBL] [Abstract][Full Text] [Related]
35. [Advances in antitumor activity of the hsp90 inhibitor geldanamycin].
Liao ZY; Zhen YS
Yao Xue Xue Bao; 2001 Sep; 36(9):716-20. PubMed ID: 12580116
[No Abstract] [Full Text] [Related]
36. Features of the Streptomyces hygroscopicus HtpG reveal how partial geldanamycin resistance can arise with mutation to the ATP binding pocket of a eukaryotic Hsp90.
Millson SH; Chua CS; Roe SM; Polier S; Solovieva S; Pearl LH; Sim TS; Prodromou C; Piper PW
FASEB J; 2011 Nov; 25(11):3828-37. PubMed ID: 21778327
[TBL] [Abstract][Full Text] [Related]
37. Potent non-benzoquinone ansamycin heat shock protein 90 inhibitors from genetic engineering of Streptomyces hygroscopicus.
Menzella HG; Tran TT; Carney JR; Lau-Wee J; Galazzo J; Reeves CD; Carreras C; Mukadam S; Eng S; Zhong Z; Timmermans PB; Murli S; Ashley GW
J Med Chem; 2009 Mar; 52(6):1518-21. PubMed ID: 19231864
[TBL] [Abstract][Full Text] [Related]
38. [Roles of geldanamycin biosynthetic genes in Streptomyces hygroscopicus 17997].
He W; Liu Y; Sun G; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1133-9. PubMed ID: 18837385
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization of macbecin as an Hsp90 inhibitor.
Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ
J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
